NEWS & MEDIA

We’re not only at the front lines of therapeutic advancement, we’re also continuously making headlines in healthcare, business, and research markets.

PRESS RELEASES

BeyondSpring Announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data Showing Plinabulin, in Combination with Pegfilgrastim, Reverses the Immune-Suppressive Effects of Pegfilgrastim and Offers Superior Prevention of Chemotherapy-Induced Neutropenia (CIN) at the FOCIS Annual Meeting

Presentation data demonstrates that plinabulin, in combination with pegfilgrastim, not only improves CIN prevention but also reverses some of the immune suppressive profile of monotherapy pegfilgrastim NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the...

read more

MEDIA

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.